Hikma Pharmaceuticals (HKMPY) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Hikma Pharmaceuticals

    OTC: HKMPY · Real-Time Price · USD
    49.25
    -0.15 (-0.30%)
    At close: Oct 03, 2025, 12:19 PM
    49.25
    0.00%
    Pre-market: Oct 03, 2025, 09:44 AM EDT

    Hikma Pharmaceuticals Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 188M 205M 270M 426M
    Short-Term Investments
    		 25M 24M 22M 24M
    Long-Term Investments
    		 51M 75M 53M 33M
    Other Long-Term Assets
    		 44M 38M 22M 24M
    Receivables
    		 905M 789M 777M 784M
    Inventory
    		 986M 891M 776M 695M
    Other Current Assets
    		 86M 119M 80M 100M
    Total Current Assets
    		 2.26B 2.1B 2B 2.09B
    Property-Plant & Equipment
    		 1.33B 1.14B 1.08B 1.15B
    Goodwill & Intangibles
    		 1.16B 1.1B 1.12B 892M
    Total Long-Term Assets
    		 2.87B 2.58B 2.47B 2.28B
    Total Assets
    		 5.13B 4.68B 4.47B 4.37B
    Account Payables
    		 358M 309M 291M 262M
    Deferred Revenue
    		 n/a n/a 193M 294M
    Short-Term Debt
    		 642M 150M 139M 112M
    Other Current Liabilities
    		 863M 869M 173M -23M
    Total Current Liabilities
    		 1.98B 1.34B 1.08B 1.02B
    Long-Term Debt
    		 607M 975M 1.07B 651M
    Other Long-Term Liabilities
    		 133M 77M 92M 140M
    Total Long-Term Liabilities
    		 834M 1.13B 1.25B 889M
    Total Liabilities
    		 2.81B 2.47B 2.32B 1.91B
    Total Debt
    		 1.31B 1.19B 1.28B 846M
    Book Value
    		 2.32B 2.21B 2.15B 2.47B
    Book Value Per Share
    		 20.97 19.87 19.20 21.36
    Common Stock
    		 40M 40M 40M 42M
    Retained Earnings
    		 2.36B 2.16B 2.09B 2.19B
    Comprehensive Income
    		 -337M -282M -279M -60M
    Shareholders Equity
    		 2.31B 2.2B 2.13B 2.45B
    Total Investments
    		 76M 99M 75M 57M

    Add to Watchlist